Aspen to wrap up senior stage this week
The senior stage of South African pharma Aspen's $2bn new money loan is due to close this week, with lenders expecting the deal to have attracted plenty of commitments already as it heads into general syndication.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
